FILTER
FILTERED INTERVIEW RESULTS
Rui Feng
CHAIRMAN AND CEO, SILVERCORP METALS INC.
Silvercorp is a low-cost silver-producing Canadian mining company with multiple mines in China.
Stan Wholley
PRESIDENT - AMERICAS, CSA GLOBAL
CSA Global provides technical and expert services, training and independent corporate advice to the mining industry.
Dany Pelletier & Serge Cotes
VICE PRESIDENT, STRUCTURING CAPITAL, ENERGY, ENVIRONMENT AND MINING & SENIOR INVESTMENT ADVISOR: FONDS DE SOLIDARITÉ FTQ.
The Fonds de solidarité FTQ is a Québec development capital organization dedicated to investing in local businesses to further economic development.
Jörgen Sjöstedt
MANAGING DIRECTOR, VOLVO GROUP PERU
Volvo Group Peru is expanding its market share in the region and increasingly focused on opportunities in the construction segment.
Ted Moses O.Q
President, SAENCAT
The Secretariat promotes sustainable relations and socio-economic alliances across the region to foster harmonious development.
Michael Gribbons
VICE PRESIDENT OF SALES AND MARKETING AND CO-FOUNDER, MAESTRO DIGITAL MINE
Maestro Digital Mine manufacturers IoT and control instrumentation for the optimization of underground mine ventilation and underground digital networks.
Alain Carrier, Carl Pelletier & Denis Gourde
CO-FOUNDER, CO-FOUNDER & VP, INNOVEXPLO
InnovExplo is an independent consulting firm in geology, mining engineering and sustainable development.
Adriaan Bakker
PRESIDENT & CEO, VANADIUMCORP
VanadiumCorp aims to become a leading supplier of battery materials and specialty metals for the emerging energy storage market.
Shawn Ryan, & David D’Onofrio
CTO & CEO, WHITE GOLD CORP.
White Gold Corp. is the largest landholder in the Yukon's White Gold District with 13 projects on 37 properties.
Tom Paterson
SENIOR VP SHIP OWNING, ARCTIC AND PROJECTS, FEDNAV LIMITED
Fednav is Canada's largest ocean-going dry-bulk shipowning and chartering group.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
United States Life Sciences 2023
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
